Page last updated: 2024-10-23

buformin and Neoplasms

buformin has been researched along with Neoplasms in 4 studies

Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"Metabolic reprogramming in cancer is considered to be one of the most important hallmarks to drive proliferation, angiogenesis, and invasion."1.91Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study. ( Arredondo-Espinoza, EU; Balderas-Renteria, I; Carranza-Rosales, P; Espinosa-Rodriguez, BA; Mendez-Lopez, LF; Ramirez-Cabrera, MA; Ramirez-Estrada, K; Treviño-Almaguer, D, 2023)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Espinosa-Rodriguez, BA1
Treviño-Almaguer, D1
Carranza-Rosales, P1
Ramirez-Cabrera, MA1
Ramirez-Estrada, K1
Arredondo-Espinoza, EU1
Mendez-Lopez, LF1
Balderas-Renteria, I1
Lu, M1
Xing, H1
Cheng, L1
Liu, H1
Lang, L1
Yang, T1
Zhao, X1
Xu, H1
Ding, P1
Anisimov, VN1
Semenchenko, AV1
Yashin, AI1
Dil'man, VM1
Bershteĭn, LM1
Tsyrlina, EV1
Bobrov, IuF1
Kovaleva, IG1

Reviews

1 review available for buformin and Neoplasms

ArticleYear
A dual-functional buformin-mimicking poly(amido amine) for efficient and safe gene delivery.
    Journal of drug targeting, 2020, Volume: 28, Issue:9

    Topics: AMP-Activated Protein Kinases; Animals; Buformin; Cell Line, Tumor; Gene Transfer Techniques; Geneti

2020

Other Studies

3 other studies available for buformin and Neoplasms

ArticleYear
Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study.
    International journal of molecular sciences, 2023, Mar-10, Volume: 24, Issue:6

    Topics: AMP-Activated Protein Kinases; Antimalarials; Biguanides; Buformin; Creatine; Humans; Metformin; Mol

2023
Insulin and longevity: antidiabetic biguanides as geroprotectors.
    Biogerontology, 2003, Volume: 4, Issue:5

    Topics: Aging; Animals; Buformin; Female; Humans; Hypoglycemic Agents; Insulin; Longevity; Mice; Neoplasms;

2003
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin].
    Voprosy onkologii, 1975, Volume: 21, Issue:11

    Topics: Adrenal Cortex Hormones; Aged; Biguanides; Blood Glucose; Body Weight; Breast Neoplasms; Buformin; C

1975